Switch to Dry-Powder Inhalers Tied to Higher ED Visits and Hospitalizations in COPD and Asthma Patients: JAMA

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2025-07-17 00:30 GMT | Update On 2025-07-17 06:18 GMT

A recent Veterans Health Administration (VHA) study published in the Journal of American Medical Association revealed that switching from metered-dose inhalers (MDIs) to dry-powder inhalers (DPIs) following a formulary change was associated with a rise in emergency department visits and hospitalizations among patients with COPD or asthma.

In July 2021, the VHA replaced the budesonide-formoterol MDI with the propellant-free fluticasone-salmeterol DPI across its national formulary for treating asthma and chronic obstructive pulmonary disease (COPD). This research evaluated outcomes from 2,60,000 U.S. veterans before and after the switch using a self-controlled case series (SCCS) and a matched cohort study design.

The primary outcomes measured included rescue medication use (albuterol and prednisone), emergency department (ED) visits, and hospitalizations (all-cause, respiratory-related, and pneumonia-specific).

Among patients who transitioned inhalers and experienced adverse events, the SCCS found a 10% decrease in albuterol prescriptions, which indicated potentially fewer acute breathing episodes requiring rescue inhalers. However, that benefit was offset by a 2% rise in prednisone use, typically a marker of worsening respiratory symptoms.

More concerning was the 5% increase in all-cause ED visits, an 8% increase in overall hospitalizations, a 10% increase in respiratory-related hospitalizations, and a significant 24% jump in pneumonia-related hospitalizations after switching to the DPI. The matched cohort analysis, which included 2,58,557 patients, showed no meaningful difference in 6-month mortality (1.89% vs 1.90%). However, it echoed the SCCS in showing increases in health care utilization:

All-cause hospitalizations rose from 15.64% to 16.14%, respiratory-related hospitalizations increased from 2.74% to 3.15%, and pneumonia-specific admissions grew from 1.03% to 1.15%. These absolute increases may appear small, but given the large number of patients affected, the implications are significant. A total of 0.49 percentage point increase in all-cause hospitalizations translates to over 1,200 additional hospital admissions in this population.

Despite dry-powder inhalers being more environmentally sustainable, this study highlighted a trade-off between ecological benefits and patient outcomes. Overall, the findings suggest that while reducing greenhouse gas emissions is crucial, health systems must closely monitor patient outcomes and consider individual clinical needs when implementing large-scale therapeutic switches.

Reference:

Rabin, A. S., Seelye, S. M., Weinstein, J. B., Hogan, C. K., Whittington, T. N., Cano, J., Miller, S. A., Kelley, C., & Prescott, H. C. (2025). Budesonide-formoterol metered-dose inhaler vs fluticasone-salmeterol dry-powder inhaler. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2025.2299

Article Source : JAMA Internal Medicine

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Jacinthlyn Sylvia

Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Switch to Dry-Powder Inhalers Tied to Higher ED Visits and Hospitalizations in COPD and Asthma Patients: JAMA

Similar News

Rheumatoid Arthritis-Linked Lung Disease Significantly Raises Risk of Death, Finds Study

Pediatric pulmonary arterial hypertension Deaths Drop by 58 Percent, But India Remains Worst-Hit: Study Reveals

BCG Revaccination Fails to Prevent TB Infection in HIV-Negative Adolescents: NEJM

Lung Ultrasound Aids Early Delirium Detection in Resource-Limited Settings: Study

Early Antibiotic Exposure in early childhood Linked to Higher Infection Risk and asthma later: Study

Silent Lung Risk: 4 Percent of Indian Teens Show Asymptomatic Bronchial Hyperresponsiveness, APEAL Study Finds

Expanding Screening Criteria by adding smoking history may Boost Detection of Lung Cancer and Reduce Disparities: JAMA